Sialylated recombinant human acetylcholinesterase (rHuAChE), produced by st
ably transfected cells, is composed of a mixed population of monomers, dime
rs and tetramers and manifests a time-dependent circulatory enrichment of t
he higher-order oligomeric forms. To investigate this phenomenon further, h
omogeneous preparations of rHuAChE differing in their oligomerization statu
ses were generated: (1) monomers, represented by the oligomerization-impair
ed C580A-rHuAChE mutant, (2) wild-type (WT) dimers and (3) tetramers of WT-
rHuAChE generated in vitro by complexation with a synthetic ColQ-derived pr
oline-rich attachment domain ('PRAD') peptide. Three different series of ea
ch of these three oligoform preparations were produced: (1) partly sialylat
ed, derived from HEK-293 cells; (2) fully sialylated, derived from engineer
ed HEK-293 cells expressing high levels of sialyltransferase; and (3) desia
lylated, after treatment with sialidase to remove sialic acid termini quant
itatively. The oligosaccharides associated with each of the various prepara
tions were extensively analysed by matrix-assisted laser desorption ionizat
ion-time-of-flight MS. With the enzyme preparations comprising the fully si
alylated series, a clear linear relationship between oligomerization and ci
rculatory mean residence time (MRT) was observed. Thus monomers, dimers and
tetramers exhibited MRTs of 110, 195 and 740 min respectively. As the leve
l of sialylation decreased, this differential behaviour became less pronoun
ced; eventually, after desialylation all oligoforms had the same MRT (5 min
). These observations suggest that multiple removal systems contribute to t
he elimination of AChE from the circulation. Hen we also demonstrate that b
y the combined modulation of sialylation and tetramerization it is possible
to generate a rHuAChE displaying a circulatory residence exceeding that of
all other known forms of native or recombinant human AChE.